Parallel down-regulation of chloride channel CLC-K1 and barttin mRNA in the thin ascending limb of the rat nephron by furosemide.
In the past few years the pivotal role of kidney Cl(-)channels (ClC-K) channels in maintaining salt and water homeostasis in the kidney has been established. The aim of the present study was to investigate the influence of the loop diuretic furosemide on the gene expression of the kidney chloride channel ClC-K1 and its recently described functional subunit barttin. Male Sprague Dawley rats received the loop diuretic furosemide (12 mg/kg/day) for 6 days. Rats had free access to 0.9% NaCl, 0.1%KCl solution to prevent volume depletion. Localisation and regulation of ClC-K1 and barttin mRNA was analysed by RNase protection and in situ hybridisation. Nephron-specific regulation was investigated by microdissection and real-time PCR quantification. In furosemide-treated rats ClC-K1 mRNA decreased to half in the inner medulla. In the renal cortex and outer medulla ClC-K1 mRNA levels were weak and did not change. Under furosemide treatment barttin mRNA was regulated in parallel with ClC-K1 mRNA. A significant mRNA decrease occurred after furosemide treatment in inner medulla (0.50 fold), whereas cortical and outer medulla levels remained unaffected. (35)S in situ hybridisation confirmed the regulation and distribution seen in the RNase protection assay experiments. Microdissection of the inner medullary collecting duct and thin limb of Henle's loop followed by real-time PCR revealed that CLC-K1 and barttin mRNA regulation in inner medulla was limited to the thin limb; mRNA levels in collecting ducts were not affected by furosemide treatment. Our findings imply that during furosemide treatment selective down-regulation of ClC-K1 and barttin mRNAs in thin limb plays a role in maintaining salt and water homeostasis.
Wolf
Konrad
K
Klinik und Poliklinik für Innere Medizin II, Klinikum der Universität Regensburg, 93042, Regensburg, Germany. konrad.wolf@klinik.uni-regensburg.de
Meier-Meitinger
Martina
M
Bergler
Tobias
T
Castrop
Hayo
H
Vitzthum
Helga
H
Riegger
Günter A J
GA
Kurtz
Armin
A
Krämer
Bernhard K
BK
D000199:Actins / Q000096:biosynthesis; D000818:Animals; D018118:Chloride Channels / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D017364:Collagenases / Q000737:chemistry; D003593:Cytoplasm / Q000378:metabolism; D004232:Diuretics / Q000494:pharmacology*; D015536:Down-Regulation / Q000502:physiology*; D005665:Furosemide / Q000494:pharmacology*; D006868:Hydrolysis; D017403:In Situ Hybridization; D007679:Kidney Medulla / Q000378:metabolism; D008297:Male; D008565:Membrane Proteins / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D009399:Nephrons / Q000187:drug effects / Q000378:metabolism*; D023282:Nuclease Protection Assays; D012333:RNA, Messenger / Q000096:biosynthesis*; D051381:Rats; D017207:Rats, Sprague-Dawley; D020133:Reverse Transcriptase Polymerase Chain Reaction
D000199:Actins; C489932:CLCNKA protein, human; D018118:Chloride Channels; C082118:Clcnka protein, rat; D004232:Diuretics; D008565:Membrane Proteins; D012333:RNA, Messenger; C486688:bsnd protein, rat; D005665:Furosemide; D017364:Collagenases